Breaking News

Cipla’s U.S. Subsidiary InvaGen Pharmaceuticals Successfully Concludes USFDA cGMP Inspection with Zero Form 483 Observations

Cipla Limited  announced that a routine current Good Manufacturing Practices (cGMP) inspection conducted by the United States Food and Drug Administration (USFDA) at the manufacturing facility of its wholly owned...

Cipla Reports Q2 FY27 Financial Results: Consolidated Net Profit Plunges 35% to ₹878 Crore on North America Drag; India Business Grows 12%

Cipla Limited today announced its consolidated financial results for the second quarter ended September 30, 2026 (Q2 FY27), reporting...

​Piramal Pharma Reports Strong Q2 FY27 Performance with 28% Revenue Growth and 72% EBITDA Surge; Upgrades Full-Year FY27 Outlook

 Piramal Pharma Limited  announced its consolidated financial results for the second quarter (Q2) and half year (H1) ended September...

Orchid Pharma Partners with Laboratorio Libra to Expand Novel Antibiotic Exblifep®️ Across Latin America in $80 Million Agreement

Orchid Pharma Ltd., a Dhanuka Group company,  announced a licensing and supply agreement with Uruguay-based LaboratorioLibra S.A. to commercialize Exblifep® (cefepime/enmetazobactam) across...

Genentech Announces Pivotal Phase III Data for Divarasib Demonstrating Significant Survival Benefits in KRAS G12C-Mutated Lung Cancer

Genentech, a member of the Roche Group, today announced positive results from the pivotal Phase III Krascendo 1 clinical trial...

Meitheal Pharmaceuticals Announces FDA Approval of Garzulys™️ Injection

Meitheal Pharmaceuticals, Inc.  announced that the U.S. Food and Drug Administration (“FDA”) has approved Garzulys™ (insulin aspart-fsan) injection, a biosimilar to NovoLog® (insulin aspart). Indicated to improve glycemic control in both...

FDA Approves Moderna’s mFLUSIVA, the First mRNA-Based Seasonal Influenza Vaccine

Moderna, Inc.  announced that the U.S. Food and Drug Administration (FDA) has approved mFLUSIVA (mRNA-1010), making it the first mRNA-based vaccine approved for seasonal influenza. The vaccine...

Government Expands Anti-Drug Operations and Rehabilitation Network in Jammu & Kashmir

The Union Ministry of Social Justice and Empowerment has reaffirmed its commitment to combating substance abuse in Jammu & Kashmir by expanding regional rehabilitation...

Health Ministry Amends Drugs Rules to Ban Misleading and Fake Documentation

The Union Ministry of Health and Family Welfare has officially issued the Drugs (Eleventh Amendment) Rules, 2026, introducing strict regulatory provisions to debar applicants...

Dr. Reddy’s Strengthens U.S. Portfolio with First Generic Sugammadex Injection Launch

Dr. Reddy’s Laboratories Ltd. has introduced SugammadexInjection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) single-dose vials, a generic equivalent of Merck's Bridion®,...

Gland Pharma and Neuland Laboratories Announce Strategic CDMO Partnership for Sterile API Manufacturing

Gland Pharma Limited and Neuland Laboratories Limited have entered into a long-term strategic Contract Development and Manufacturing Organization (CDMO) partnership to expand sterile Active...